Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
3
×
new york blog main
biotech
boston blog main
boston top stories
deals
national top stories
new york top stories
san diego blog main
san francisco
san francisco blog main
san francisco top stories
10x genomics
abbvie
acorda therapeutics
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
ampyra
apokyn
apomorphine
arch venture partners
astellas pharma
becton dickinson
boxer capital
cancer
cancer diagnostics
clinical trials
dalfampridine
diagnostic device
dravet syndrome
duopa
ed kaye
encoded therapeutics
gene therapy
generation bio
hemophilia
idiopathic pulmonary fibrosis (ipf)
What
help
3
×
treatment
3
×
acorda
adding
aims
approved
company
cope
crude
cutting
deal
decisions
despite
diagnostic
diagnostics
disease
drug
edge
effects
encoded
episodes
expand
fda
fold
friday
gene
gets
illumina’s
lasting
late
limited
limits
long
looms
make
meant
medications
medicine
nabs
nanostring
Language
unset
Current search:
treatment
×
help
×
" national blog main "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
